UK markets close in 7 hours 52 minutes
  • FTSE 100

    7,552.03
    -15.51 (-0.20%)
     
  • FTSE 250

    19,243.04
    -86.54 (-0.45%)
     
  • AIM

    847.64
    -3.08 (-0.36%)
     
  • GBP/EUR

    1.1616
    +0.0001 (+0.01%)
     
  • GBP/USD

    1.2188
    -0.0006 (-0.05%)
     
  • BTC-GBP

    13,953.34
    -366.11 (-2.56%)
     
  • CMC Crypto 200

    401.25
    -9.97 (-2.42%)
     
  • S&P 500

    3,998.84
    -72.86 (-1.79%)
     
  • DOW

    33,947.10
    -482.78 (-1.40%)
     
  • CRUDE OIL

    77.07
    +0.14 (+0.18%)
     
  • GOLD FUTURES

    1,782.80
    +1.50 (+0.08%)
     
  • NIKKEI 225

    27,885.87
    +65.47 (+0.24%)
     
  • HANG SENG

    19,441.18
    -77.11 (-0.40%)
     
  • DAX

    14,422.19
    -25.42 (-0.18%)
     
  • CAC 40

    6,688.69
    -8.27 (-0.12%)
     

Cholesterol Tests Market by 2028 | Demand, Trends, Opportunities, Challenges, Competitive Situation & Regional Analysis | Douglas Insights

Douglas Insights
Douglas Insights

Some of the top industry players striving relentlessly to capture bigger markets and penetrate new ones are AstraZeneca, Boston Scientific Corporation, Medtronic, Abbott, LivaNova PLC, Quest Diagnostics, Inc., and Spectra Lab, Inc.

Douglas, Nov. 16, 2022 (GLOBE NEWSWIRE) -- The cholesterol test market is rapidly growing worldwide. The industry is segmented by product type, test type, and region. Product types include testing strips and test kits, while tests include total cholesterol tests, HDL (high-density lipoprotein), LDL (low-density lipoprotein), and triglyceride tests. As the market has an upward trajectory, industry players aggressively invest in research and development to capture a more significant market share. Therefore, Douglas Insights added cholesterol research reports to its comparison engine to help them make better investment decisions and tap lucrative business growth opportunities.

Douglas Insights is the world’s first comparison engine that empowers analysts, experts, and organisations to select research reports and compare them. The comparison engine helps professionals compare and evaluate reports globally by price, number of pages, publisher rating, and table of contents. Using this digital tool, experts can gain valuable insights to understand market trends, drivers, restraints, and challenges. Plus, it can also be used for making quick and informed decisions.

Examine the report and make your choice here: https://douglasinsights.com/cholesterol-tests-market

Market Drivers

The cholesterol testing market is expected to grow at a compound annual growth rate of 8.37 percent from 2022 to 2029. Multiple factors are likely to contribute to market growth. The primary market driver is the decrease in physical activities. The significant drop in physical activity is associated with the sedentary nature of jobs, passive transportation modes, increasing screen time, and a preference for passive leisure activities rather than playing sports.

Studies reveal that people of all ages are insufficiently physically active. Though the World Health Organization recommends engaging in at least 60 minutes of vigorous or moderate-intensity physical activity, most people fail to do so. Hence, it is becoming increasingly common for people to have high cholesterol levels. Physical activities like exercise, swimming, and jogging effectively lower LDL (bad) cholesterol and increase HDL (good) cholesterol levels in the body. These activities can easily protect people from the risk of developing cardiovascular diseases.

Since there has been a drop in physical activity and more people are suffering from cardiovascular diseases, the need for cholesterol-level testing strips and kits is rising. Moreover, as high cholesterol usually has no symptoms or signs, it is vital to get it tested. A complete cholesterol test can help determine high cholesterol levels and the risk of heart attacks and other types of cardiovascular diseases and diseases of the blood vessels.

On the other hand, increasing health awareness is another key driver of market growth. Health-conscious people seek regular screenings and check-ups to manage their cholesterol levels better. This attitudinal shift has indeed triggered the demand for OTC self-testing kits. These testing devices help patients check their cholesterol levels and make lifestyle changes and effective healthcare measures to minimise the risk of cardiovascular diseases, which can block arteries and be fatal. With cholesterol test kits and devices, early detection is possible and much needed for quality and healthy living.

The growing demand for cholesterol testing products has increased the competition globally. Some of the top industry players striving relentlessly to capture bigger markets and penetrate new ones are AstraZeneca, Boston Scientific Corporation, Medtronic, Abbott, LivaNova PLC, Quest Diagnostics, Inc., and Spectra Lab, Inc.. As per the regional analysis, North America has the highest market share and is expected to lead the global industry for the forecasted period, followed by the APAC region, including countries like China and Japan. Because the APAC region's population is rapidly aging, the demand for cholesterol testing devices is expected to skyrocket in the coming years.

Key players

Some major players operating in the global cleaning robot market are AstraZeneca, Boston Scientific Corporation, Medtronic, Abbott, LivaNova PLC, Quest Diagnostics Incorporated, and Spectra Lab, Inc.

Set a budget for a custom project and see offers from publishers all over the world: https://douglasinsights.com/projects

Cholesterol Tests: Market Report Coverage

Report Attributes

Details

market size in 2018

US$ ** BN

Market Size Projection in 2028

US$** BN

CAGR (2018-2028)

 8.37%

Largest Market

North America

Report Segmentation

By type, by application, and by region

Regional Analysis

North America (the United States and Canada), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), Europe (the United Kingdom, Germany, Italy, France, Spain, Russia, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, ASEAN, and the Rest of Asia Pacific), Middle East (GCC Countries, Israel, and the Rest of the Middle East), and Africa (South Africa, North Africa, and Central Africa).

Key Companies Covered

AstraZeneca, Boston Scientific Corporation, Medtronic, Abbott, LivaNova PLC, Quest Diagnostics Incorporated, and Spectra Lab, Inc.

 

Segmentations

By Product

  • Introduction

  • Lipid profile tests

  • Cholesterol Tests

  • HDL Tests

  • LDL Tests

  • Triglyceride Tests

  • Point-of-Care Tests

Key questions are answered in this report.

  • COVID-19 impact analysis on the global cholesterol testing industry

  • What are the current market trends and dynamics in the cholesterol tests market, and what are the valuable opportunities for emerging players?

  • What is driving the market for cholesterol tests?

  • What are the key challenges to market growth?

  • Which segment accounts for the fastest CAGR during the forecast period?

  • Which product type segment holds a larger market share and why?

  • Are low- and middle-income economies investing in the cholesterol testing market?

  • Key growth pockets on the basis of regions, types, applications, and end-users

  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and the Middle East and Africa?

Unique data points of this report

  • Statistics on Cholesterol Tests and Spending Worldwide

  • Recent trends across different regions in terms of the adoption of cholesterol tests across industries

  • Notable developments are going on in the industry.

  • Attractive investment propositions for segments as well as geography

  • Comparative scenario for all the segments for years 2018 (actual) and 2028 (forecast)

Table of Content:

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
Methodology
Information Sources
Primary Research
Secondary Research
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports


Chapter 2 Summary and Highlights
Introduction


Chapter 3 Market Definitions and Disease Background
Cholesterol
Functions of Cholesterol
Role of Cholesterol in Hormone Production
Cholesterol and Vitamin D Synthesis
Cholesterol and Bile Acid Production
Cholesterol and the Immune System
Cholesterol Metabolism
Sources of Cholesterol
Clinical Significance of Cholesterol
Total Blood (Serum) Cholesterol
Triglycerides
Definitions
Lipid Profile
POC Cholesterol Tests
Cholesterol Determination: Methods and Techniques
Methods of Cholesterol Measurements
Disease Background
Dyslipidemias
Hypercholesterolemia
Hypertriglyceridemia
Hyperlipidemia
Tangier Disease
Atheroembolic Kidney Disease
Atherosclerosis
Heart Disease


Chapter 4 Market Trends
Market Drivers
Aging Population
Risk Indicators in Major Countries
Mean Total Cholesterol level
Prevalence of Obesity
Prevalence of Hypertension
Growing Prevalence and Incidence
Increasing Healthcare Expenditures
Penetration of Medical Devices in Emerging Markets
Market Restraints
Market Impact


Chapter 5 Market Breakdown by Product
Introduction
Lipid Profile Tests
Cholesterol Tests
HDL Tests
LDL Tests
Triglyceride Tests
Point-of-Care Tests


Chapter 6 Impact of COVID-19
Introduction
Impact of COVID-19 on the Medical Device Industry
Decline/Delay in Elective Procedures
Impact of COVID-19 on the Supply Chain
Impact of COVID-19 on the U.S. Supply Chain
Impact of COVID-19 on the European Supply Chain
Impact of COVID-19 on the APAC Supply Chain
Impact of COVID-19 on China
Impact of COVID-19 on Medical Device Product Segments
Impact of COVID-19 on Critical Devices
Impact of COVID-19 on Cholesterol Testing Markets


Chapter 7 Market Breakdown by Region
Market Overview
North America
United States
Canada
Mexico
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
Rest of the World

…………….. ToC continued

Compare the report and make your decision - https://douglasinsights.com/cholesterol-tests-market

Inquire Before Buying This Research Report: https://douglasinsights.com/static/contact-us

Follow Douglas Insights For More Industry Updates- @ LinkedIn Twitter

About Douglas Insights-

Douglas Insights UK limited is the first company to provide comparison of market research reports by Table of content, price, ratings and number of pages. We understand the value of time. Productivity and efficiency are possible when you take prompt and assured decisions. With our advanced algorithm, filters, and comparison engine, you can compare your preferred reports simultaneously, based on publisher rating, published date, price, and list of tables. Our data portal enables you to find and review the reports from several publishers. You can evaluate numerous reports on the same screen and select the sample for your best match.

Similar Market Research Report Comparisons:

Point Of Care Cholesterol Monitoring Device Market: In the following years, the global Point-of-Care Cholesterol Monitoring Device Market will soar to new heights.The market for point-of-care cholesterol monitoring devices is likely driven by the rising prevalence of target diseases such as cardiovascular disease, diabetes, and dyslipidemia.

Fertility Test Market: Global Fertility Test Market is valued approximately at USD 414.5 million in 2018 and is anticipated to grow with a healthy growth rate of more than 7.20% over the forecast period 2019-2026.

Antimicrobial Susceptibility Test Market: Global Antimicrobial Susceptibility Test Market is valued approximately at USD 3.0 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2020-2026.

Cervical Cancer Diagnostic Test Market: The global cervical cancer diagnostic test market market is growing significantly, was valued at US$ 8,779.2 Mn in 2017 and expected to attain US$ XX Mn by 2026.

CONTACT: Office- Bridge House, W Baldwin Rd, Isle of Man IM4 5HA, Isle of Man Email- isabella@douglasinsights.com Telephone - +44 7624 248772 Web- douglasinsights.com/